Pyxis Oncology (PYXS) Other Non-Current Assets (2020 - 2022)

Pyxis Oncology (PYXS) has 3 years of Other Non-Current Assets data on file, last reported at $1.5 million in Q3 2022.

• Other Non-Current Assets for Q3 2022 came in at $1.5 million, up 1250.46% year-over-year; the trailing twelve-month figure through Sep 2022 was $1.5 million (up 1250.46% YoY), and the FY2021 annual result was $109000.0, changed 0.0% from the prior year.
• Other Non-Current Assets was little changed at $1.5 million in Q3 2022 per PYXS's latest filing, from $1.5 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $1.5 million in Q2 2022 and troughed at $108000.0 in Q2 2021.
• A 3-year average of $492125.0 and a median of $109000.0 in 2020 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2021 and 2022: Other Non-Current Assets changed 0.0% in 2021, then soared 1262.96% in 2022.
• A 3-year view of Other Non-Current Assets shows it stood at $109000.0 in 2020, then changed by 0.0% to $109000.0 in 2021, then surged by 1250.46% to $1.5 million in 2022.
• Business Quant data shows PYXS's Other Non-Current Assets at $1.5 million in Q3 2022, $1.5 million in Q2 2022, and $449000.0 in Q1 2022.